The atrial fibrillation (AFib) history feature on Apple Watches can be used to track AFib during cardiac device clinical trials, the US Food and Drug Administration announced recently. It is the first digital health tool designated under the FDA’s Medical Device Development Tools (MDDT) program.
Apple Watch Feature Qualified As FDA Device Development Tool
The designation makes the watch's AFib history feature the first digital health tool to be qualified under the US FDA’s Medical Device Development Tools program, meaning it can be used in research during the development of certain cardiac devices.
More from Regulation
More from Policy & Regulation
• By
Well over 200 European standards need harmonizing under the MDR. But only around 12% have been attended to so far.
• By
The medtech industry hopes to use a 90-day pause on tariffs to negotiate a “zero for zero” exemption. However, recent public comments from President Donald Trump suggest the health care sector may still be at risk.
• By
The architect of Germany’s hospital reform, Karl Lauterbach, will not be retained as health minister according to how the new CDU/CSU-SPD coalition government plans to spread the ministerial portfolios.